MetabolicSGLT2 inhibitorScheduled campaign
Dapagliflozin
Also known as Farxiga, Forxiga
A sodium-glucose co-transporter 2 (SGLT2) inhibitor used in type 2 diabetes and heart failure. Currently at pilot scale with commercial scale-up in the roadmap.
Full specification
Identity, quality, and supply.
- INN
- Dapagliflozin
- CAS number
- 461432-26-8
- Molecular formula
- C21H25ClO6
- Molecular weight
- 408.9 g/mol
- Therapeutic area
- Metabolic
- Therapeutic class
- SGLT2 inhibitor
- Supplied as
- API + Intermediate
- Available scale
- Pilot (up to 50 kg)
- Stock status
- Scheduled campaign
- Storage
- As per COA
- Packaging
- HDPE drums, 5 kg net weight
- Brand names
- Farxiga, Forxiga
Highlights
What buyers care about.
- Pilot-scale manufacture with full analytical release
- Commercial scale-up planned Q4 2026